PetMed Express 2021 Annual Report - PETS

PetMed Express annual report for fiscal 2021 detailing company performance, financial results, and strategic initiatives. Sales increased 8.8% to $309.2 million with net income of $30.6 million, driven by strong e-commerce demand for pet medications during COVID-19. The company, operating as America's Most Trusted Pet Pharmacy through 1-800-PetMeds, continues expanding its digital platform and reaffirming its commitment to shareholder returns through dividends and share buybacks.